Consolidated Condensed Statements Of Cash Flows (USD $) In Thousands	6 Months Ended
	Jul. 01, 2011	Jul. 02, 2010
Cash flows from operating activities:
Net earnings	$ 1,078,122	$ 672,709
Less: earnings from discontinued operations, net of tax	208,230	17,840
Net earnings from continued operations	869,892	654,869
Non-cash items:
Depreciation	106,628	96,364
Amortization	118,673	94,362
Stock compensation expense	45,966	40,882
Earnings from unconsolidated joint venture, net of cash dividends received	(16,586)
Change in trade accounts receivable, net	(14,850)	(63,664)
Change in inventories	(32,280)	(157,413)
Change in accounts payable	36,658	174,265
Change in prepaid expenses and other assets	54,345	123,737
Change in accrued expenses and other liabilities	(11,733)	(47,252)
Total operating cash flows from continuing operations	1,156,713	916,150
Total operating cash flows from discontinued operations	(57,581)	15,652
Net cash flows from operating activities	1,099,132	931,802
Cash flows from investing activities:
Payments for additions to property, plant and equipment	(108,094)	(89,119)
Proceeds from disposals of property, plant and equipment	3,431	627
Cash paid for acquisitions	(6,056,279)	(1,398,526)
Total investing cash flows from continuing operations	(6,160,942)	(1,487,018)
Investing cash flows from discontinued operations	(1,521)	(3,219)
Proceeds from sale of discontinued operations	680,105
Net cash used in investing activities	(5,482,358)	(1,490,237)
Cash flows from financing activities:
Proceeds from issuance of common stock	1,050,322	92,850
Payment of dividends	(26,973)	(26,012)
Net proceeds of borrowings (maturities of 90 days or less)	462,147	21,543
Proceeds of borrowings (maturities greater than 90 days)	1,785,764
Repayments of borrowings (maturities greater than 90 days)	(2,021)
Net cash provided by financing activities	3,269,239	88,381
Effect of exchange rate changes on cash and equivalents	32,590	(18,930)
Net change in cash and equivalents	(1,081,397)	(488,984)
Beginning balance of cash and equivalents	1,632,980	1,721,920
Ending balance of cash and equivalents	551,583	1,232,936
Supplemental disclosures:
Cash interest payments	38,439	39,192
Cash income tax payments (including $53 million related to the gain on sale of the discontinued Pacific Scientific Aerospace business - refer to Note 3)	$ 162,696	$ 114,440